Cart 0
Experts in Aptamer Development & Biosensing Technologies

Taking laboratory analysis capability into the field

Since its inception in 2015, AuramerBio has been paving the way in aptamer-based biosensors. AuramerBio was founded at Victoria University of Wellington (New Zealand) when scientists within the university undertaking complementary research teamed up to develop high quality diagnostic applications at cost effective prices.

We develop next generation diagnostic solutions for both the medical and environmental fields.

AuramerBio is currently working on commercializing our biosensors. Our initial product offerings will be illicit drug detection and fertility monitoring. See our products page for more information.

We also develop custom aptamers and aptamer-based biosensors for a wide range of clients. See our Custom Aptamer page for more information on the services we provide.

The AuramerBio Team

Our team has a wide skill-base positioning us perfectly to rapidly deploy aptamers into a range of analytical assay and device platforms.


Shalen kumar, PhD


Founding inventor of our technology platform and SELEX expert, Shalen has over 10 years experience in the development of aptamers and integration in various sensing platforms. Shalen heads the team and the technical development of products and partnership management.


Kelly Campen, PHd


Kelly has over 10 years experience in molecular biology. Kelly heads the Custom Aptamer Development Business, oversees product innovation and development, customer relations and supports technical R&D projects.


Jennifer Soundy, PhD

Senior Scientist

Jennifer has 4 years of experience in aptamer development with a background in therapeutic bacterial aptamer research. Jennifer brings her expertise in microbiology, molecular biology and nanotechnology to the custom aptamer development program.


Ken McNatty, PhD

Scientific Advisor

Ken is a highly decorated internationally recognised scientist within the fertility field. His passion and vision for innovative science project led to the foundation of aptamer research in New Zealand. During his research career, Ken has published over 300 scientific publications in peer reviewed journals, whilst also being an inventor in over 10 patents. Ken’s experience with commercialisation (AndroVax®) has been key in guiding the science team.


Janet Pitman, PhD

Scientific Advisor

Janet has a wealth of knowledge in the reproductive biology and molecular diagnostics field. Janet has developed a number of ultrasensitive real time PCR assays critical for identifying key markers that indicate the fertility status. Janet works closely with the Science team on daily basis and oversees the management of the lab.


The AuramerBio directors


Graeme Benny

Director & Chair

Graeme has over 25 years of senior executive experience in the private sector and New Zealand government public sector. He is currently Chair and/or Board Member/Director of 8 companies in NZ and Australia. Not only does he bring his extensive governance and executive management experience to AuramerBio but also many years of experience as a clinical biochemist in the NZ health and biotechnology sectors.


John Bone


John's passion for technical innovation, customer relationships and commercial enterprise has been applied to a number of roles across the commercial sector including chemical, oil, technology and telecommunications. He has over 15 years senior leadership experience in business and technology. Currently John oversees all of ESR’s forensic business group activities.


Geoff Todd


Geoff has extensive experience in raising capital, buying and selling technology businesses, formulating joint venture agreements and adding significant commercial value to technology projects. He is currently Managing Director of Viclink, serves on a number of technology and medical companies, and is a core participant in a start-up medical device company.



Melissa Yiannoutsos


Melissa is highly experienced in healthcare commercialisation in both the private and public sectors. Her investment track record has resulted in excess of $30M raised for NZ technology companies. An alumna of the Entrepreneur Programme at MIT, Melissa has held executive roles in technology start-ups since 2012, leading strategic growth, establishing international sales and negotiating key partnerships.